Quality of life assessment. An independent prognostic variable for survival in lung cancer
Open Access
- 15 June 1991
- Vol. 67 (12) , 3131-3135
- https://doi.org/10.1002/1097-0142(19910615)67:12<3131::aid-cncr2820671232>3.0.co;2-4
Abstract
Improved quality of life has long been the goal of cancer treatment, but only recently have investigators begun to include a systematic assessment of quality of life in clinical trials. The major interest for its inclusion in clinical trials has been to assess treatment outcome. An evaluation of the relationship between patient‐rated quality of life and survival is reported in a homogeneous sample of patients with advanced metastatic lung cancer participating in a clinical trial. Under the Cox proportional‐hazards model (with quality of life, marital status, and their interaction in the model), a statistically significant relationship was observed between initial patient‐rated quality of life and subsequent survival. In addition, being married led to a significantly improved survival. These findings suggest that nonmedical factors, such as quality of life assessment and marital status, play a role in survival and that they should be evaluated and described as potential predictors of survival in cancer patients in clinical trials.Keywords
This publication has 13 references indexed in Scilit:
- Assessing the quality of life—a study in newly-diagnosed breast cancer patientsJournal of Clinical Epidemiology, 1990
- Do We Need a New End Point in Clinical Trials Today?JNCI Journal of the National Cancer Institute, 1989
- Prognostic factors for patients with inoperable non-small cell lung cancer, limited diseaseRadiotherapy and Oncology, 1989
- Quality of Life End Points in Cancer Clinical Trials: Review and RecommendationsJNCI Journal of the National Cancer Institute, 1989
- Quality of Life Assessment in Cancer Clinical Trials-It's Time To Catch UpJNCI Journal of the National Cancer Institute, 1989
- Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?Cancer, 1989
- Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the functional living index—cancerCancer, 1988
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.Journal of Clinical Oncology, 1984
- PSYCHOLOGICAL RESPONSE TO BREAST CANCER: EFFECT ON OUTCOMEThe Lancet, 1979